Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration

To assess pharmacodynamic responses to ranibizumab, an inhibitor of vascular endothelial growth factor A (VEGF-A), in a study of the treatment of minimally classic or occult with no classic choroidal neovascularization secondary to age-related macular degeneration (AMD) (designated MARINA [Minimally...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Ophthalmology (Rochester, Minn.) Jg. 114; H. 10; S. 1868
Hauptverfasser:	Kaiser, Peter K, Blodi, Barbara A, Shapiro, Howard, Acharya, Nisha R
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.10.2007
Schlagworte:	Aged Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - pharmacology Antibodies, Monoclonal, Humanized Choroidal Neovascularization - diagnosis Choroidal Neovascularization - drug therapy Double-Blind Method Female Fluorescein Angiography Humans Injections Macular Degeneration - diagnosis Macular Degeneration - drug therapy Male Ranibizumab Retrospective Studies Tomography, Optical Coherence Treatment Outcome Vascular Endothelial Growth Factor A - antagonists & inhibitors Visual Acuity - drug effects Vitreous Body
ISSN:	1549-4713, 1549-4713
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!